为您找到相关结果约225个

你是不是要搜索 期刊VRd 点击跳转

DREAMM-9: Phase III study of belantamab mafodotin plus VRd versus VRd alone in transplant-ineligible

Efficacy of Modified Vrd-Lite for Transplant Ineligible Multiple Myeloma

CLINICAL EXPERIENCE WITH FIRST-LINE VRD IN MULTIPLE MYELOMA DIAGNOSTIC PATIENTS

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple

VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple

Obituary: Dr Basil Morson, CBE, VRD, DM, FRCPath, FRCSE, FRCP, FRACS (1921-2016)

Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD

Predictors of response to upfront bortezomib, lenalidomide and dexamethasone (VRd) in multiple myeloma

Advantage of achieving deep response following frontline daratumumab-VTd compared to VRd in transplant-eligible

Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and

From VAD to VRD Is Transplant Still Needed in the Upfront Setting of Myeloma?

Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd)

Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients

Vrd induction therapy drives memory like NK cell development in newly diagnosed multiple myeloma patients

Efficacy and Safety Analysis of VRD-PDCE in Treatment-Native Patients with Multiple Extramedullary Plasmacytomas

为您找到相关结果约225个

共225条页码: 1/15页15条/页